Evidence map›Paper›PMID 27119498›Full record

ArticleOncotarget2016

Vitamin D3 suppresses morphological evolution of the cribriform cancerous phenotype.

Ravi K Deevi, Jane McClements, Karen D McCloskey, Aliya Fatehullah, Dorota Tkocz, Arman Javadi, Robyn Higginson, Victoria Marsh Durban, Marnix Jansen, Alan Clarke and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Ravi K DeeviCentre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, UK.
Jane McClementsCentre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, UK.
Karen D McCloskeyCentre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, UK.
Aliya FatehullahCentre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, UK.
Dorota TkoczCentre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, UK.
Arman JavadiCentre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, UK.
Robyn HigginsonCentre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, UK.
Victoria Marsh DurbanEuropean Cancer Stem Cell Research Institute, Cardiff University, Cardiff, UK.
Marnix JansenBarts Cancer Institute, Queen Mary University of London, John Vane Science Centre, London, UK.
Alan ClarkeEuropean Cancer Stem Cell Research Institute, Cardiff University, Cardiff, UK.
Maurice B LoughreyNorthern Ireland Molecular Pathology Laboratory, Centre for Cancer Research and Cell Biology, Queens University Belfast and Belfast Health and Social Care Trust, Belfast, UK.
Frederick C CampbellCentre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, UK.
Queen's University Belfast · GBCardiff University · GBQueen Mary University of London · GB

Funding

Cancer Research UK 15342
6 · The paper itself

Abstract

Development of cribriform morphology (CM) heralds malignant change in human colon but lack of mechanistic understanding hampers preventive therapy. This study investigated CM pathobiology in three-dimensional (3D) Caco-2 culture models of colorectal glandular architecture, assessed translational relevance and tested effects of 1,25(OH)2D3,theactive form of vitamin D. CM evolution was driven by oncogenic perturbation of the apical polarity (AP) complex comprising PTEN, CDC42 and PRKCZ (phosphatase and tensin homolog, cell division cycle 42 and protein kinase C zeta). Suppression of AP genes initiated a spatiotemporal cascade of mitotic spindle misorientation, apical membrane misalignment and aberrant epithelial configuration. Collectively, these events promoted "Swiss cheese-like" cribriform morphology (CM) comprising multiple abnormal "back to back" lumens surrounded by atypical stratified epithelium, in 3D colorectal gland models. Intestinal cancer driven purely by PTEN-deficiency in transgenic mice developed CM and in human CRC, CM associated with PTEN and PRKCZ readouts. Treatment of PTEN-deficient 3D cultures with 1,25(OH)2D3 upregulated PTEN, rapidly activated CDC42 and PRKCZ, corrected mitotic spindle alignment and suppressed CM development. Conversely, mutationally-activated KRAS blocked1,25(OH)2D3 rescue of glandular architecture. We conclude that 1,25(OH)2D3 upregulates AP signalling to reverse CM in a KRAS wild type (wt), clinically predictive CRC model system. Vitamin D could be developed as therapy to suppress inception or progression of a subset of colorectal tumors.

Indexed as

AdenocarcinomaAnimalsCaco-2 Cellscdc42 GTP-Binding ProteinCell Culture TechniquesCell Transformation, NeoplasticCholecalciferolCohort StudiesColonColorectal NeoplasmsGene Expression Regulation, NeoplasticHumansMiceMice, TransgenicMitosisMutationcdc42 GTP-Binding ProteinCholecalciferolProtein Kinase CProtein Kinase C zetaPTEN PhosphohydrolasePTEN protein, humanPten protein, mouseReceptors, CalcitriolVDR protein, humancolorectal cancermolecular oncologymorphologyprognosisvitamin D receptor gene

Identifiers

PMID27119498
PMCPMC5226489
OpenAlexW2339260593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.